Rotterdam, Netherlands

Johannes N M Yzermans

This inventor holds 1 USPTO granted patent. Top assignee: Biotempt B.v.. Active years: 2009.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Johannes N M Yzermans. Retrieved from https://idiyas.com/inventor/johannes-n-m-yzermans

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2009

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Transplant Medicine by Johannes N M Yzermans

Introduction

Johannes N M Yzermans is a notable inventor based in Rotterdam, Netherlands. He has made significant contributions to the field of transplantation medicine, particularly in the prevention and treatment of transplant rejection. His innovative approach aims to enhance transplant survival rates for recipients.

Latest Patents

Yzermans holds a patent for a method related to the treatment of transplant survival. This invention focuses on modulating transplant survival in recipients by providing the transplant with a gene-regulatory peptide or a functional analogue thereof. The patent outlines the use of this peptide for producing a pharmaceutical composition that aids in preventing chronic rejection of transplants.

Career Highlights

Throughout his career, Yzermans has been associated with Biotempt B.V., where he has worked on advancing medical technologies. His expertise in transplantation medicine has positioned him as a key figure in developing solutions that improve patient outcomes.

Collaborations

Yzermans has collaborated with professionals such as Nisar Ahmed Khan and Robbert Benner, contributing to a dynamic work environment focused on innovation in medical science.

Conclusion

Johannes N M Yzermans exemplifies the spirit of innovation in the field of transplantation medicine. His work continues to influence the way transplant rejection is managed, ultimately benefiting patients in need of transplants.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…